If copies of Teva's Copaxone hit, oral MS rivals could be the real threat

If copies of Teva's Copaxone hit, oral MS rivals could be the real threat

Submitted by admin on February 15, 2017 - 9:41am
Source: 
Fierce Pharma
News Tags: 
Teva Pharmaceutical
Copaxone
MS
multiple sclerosis
generics
Tecfidera
Biogen
Gilenya
Novartis
Aubagio
Sanofi
Headline: 
If copies of Teva's Copaxone hit, oral MS rivals could be the real threat

Do Not Allow Advertisers to Use My Personal information